ArticleJIMD reports2016

Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse Brain.

Helen Beard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.